This inventor holds 1 USPTO granted patent. Top assignee: Wyeth Holdings Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Xue-Mei Du: Innovator in Pharmaceutical Chemistry
Introduction
Xue-Mei Du is a prominent inventor based in Valley Cottage, NY (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various disease conditions.
Latest Patents
Xue-Mei Du holds one patent titled "Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors." This patent focuses on compounds that are useful in treating diseases mediated by TNF-α, including rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease, and degenerative cartilage loss.
Career Highlights
Xue-Mei Du is currently associated with Wyeth Holdings Corporation, where she applies her expertise in pharmaceutical research and development. Her work has been instrumental in advancing therapeutic options for patients suffering from chronic and debilitating conditions.
Collaborations
Some of her notable coworkers include Jeremy Ian Levin and James Ming Chen, who have collaborated with her on various research projects within the pharmaceutical sector.
Conclusion
Xue-Mei Du's innovative work in developing TACE inhibitors showcases her commitment to improving healthcare outcomes. Her contributions to pharmaceutical chemistry continue to have a lasting impact on the treatment of serious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile